{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:21:38Z","timestamp":1790734898853,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ebiom.2024.105458","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T05:12:28Z","timestamp":1732684348000},"page":"105458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["FGF21 and its underlying adipose tissue-liver axis inform cardiometabolic burden and improvement in obesity after metabolic surgery"],"prefix":"10.1016","volume":"110","author":[{"given":"Marie","family":"Patt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Karkossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Krieg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Massier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kassem","family":"Makki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Tabei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8109-8526","authenticated-orcid":false,"given":"Thomas","family":"Karlas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Gericke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stumvoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Bl\u00fcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"von Bergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9901-1815","authenticated-orcid":false,"given":"Rima M.","family":"Chakaroun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ebiom.2024.105458_bib1","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1038\/s41591-024-03095-3","article-title":"A new framework for the diagnosis, staging and management of obesity in adults","volume":"30","author":"Busetto","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2024.105458_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-0029-1192044","article-title":"Adipose tissue dysfunction in obesity","volume":"117","author":"Bl\u00fcher","year":"2009","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105458_bib3","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics\u20142020 update: a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ebiom.2024.105458_bib4","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.2337\/dc15-1081","article-title":"Advances in the science, treatment, and prevention of the disease of obesity: reflections from a diabetes care editors' expert forum","volume":"38","author":"Cefalu","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ebiom.2024.105458_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-med-053117-123246","article-title":"Bariatric surgery as a long-term treatment for type 2 diabetes\/metabolic syndrome","volume":"71","author":"Hanipah","year":"2020","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.ebiom.2024.105458_bib6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cmet.2015.12.003","article-title":"FGF21 mediates endocrine control of simple sugar intake and sweet taste preference by the liver","volume":"23","author":"von Holstein-Rathlou","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.ebiom.2024.105458_bib7","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1055\/a-0879-2968","article-title":"Circulating FGF21 levels in human health and metabolic disease","volume":"128","author":"Keuper","year":"2020","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.ebiom.2024.105458_bib8","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1210\/en.2009-0221","article-title":"Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity","volume":"150","author":"Berglund","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.ebiom.2024.105458_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molmet.2012.08.007","article-title":"The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue","volume":"2","author":"Adams","year":"2012","journal-title":"Mol Metab"},{"key":"10.1016\/j.ebiom.2024.105458_bib10","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.66519","article-title":"OPA1 deletion in brown adipose tissue improves thermoregulation and systemic metabolism via FGF21","volume":"10","author":"Pereira","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.ebiom.2024.105458_bib11","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/S0140-6736(18)31785-9","article-title":"Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial","volume":"392","author":"Sanyal","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2024.105458_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/oby.22344","article-title":"Pegbelfermin (BMS-986036), PEGylated FGF21, in patients with obesity and type 2 diabetes: results from a randomized phase 2 study","volume":"27","author":"Charles","year":"2019","journal-title":"Obesity"},{"key":"10.1016\/j.ebiom.2024.105458_bib13","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41574-020-0386-0","article-title":"The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic","volume":"16","author":"Geng","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ebiom.2024.105458_bib14","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.2337\/dc09-0684","article-title":"Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance","volume":"32","author":"Chavez","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ebiom.2024.105458_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/cen.12134","article-title":"Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status","volume":"80","author":"Lee","year":"2014","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ebiom.2024.105458_bib16","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/cen.12496","article-title":"Calorie restriction and Roux-en-Y gastric bypass have opposing effects on circulating FGF21 in morbidly obese subjects","volume":"81","author":"Lips","year":"2014","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ebiom.2024.105458_bib17","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/ijo.2017.138","article-title":"Plasma FGF21 levels in obese patients undergoing energy-restricted diets or bariatric surgery: a marker of metabolic stress?","volume":"41","author":"Crujeiras","year":"2017","journal-title":"Int J Obes"},{"key":"10.1016\/j.ebiom.2024.105458_bib18","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1007\/s11695-020-04807-7","article-title":"Surgery-induced weight loss and changes in hormonally active fibroblast growth factors: a systematic review and meta-analysis","volume":"30","author":"Hosseinzadeh","year":"2020","journal-title":"Obes Surg"},{"key":"10.1016\/j.ebiom.2024.105458_bib19","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.clnu.2016.04.027","article-title":"FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss","volume":"36","author":"G\u00f3mez-Ambrosi","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.ebiom.2024.105458_bib20","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc19-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019","volume":"42","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ebiom.2024.105458_bib21","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jand.2016.10.030","article-title":"Dietary assessment in the MetaCardis study: development and relative validity of an online food frequency questionnaire","volume":"117","author":"Verger","year":"2017","journal-title":"J\u00a0Acad Nutr Diet"},{"key":"10.1016\/j.ebiom.2024.105458_bib22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.ebiom.2024.105458_bib23","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1007\/s11695-015-2022-y","article-title":"Total weight loss as the outcome measure of choice after Roux-en-Y gastric bypass","volume":"26","author":"Corcelles","year":"2016","journal-title":"Obes Surg"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105458_bib24","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1136\/gutjnl-2021-324603","article-title":"Multiomics reveal unique signatures of human epiploic adipose tissue related to systemic insulin resistance","volume":"71","author":"Krieg","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.ebiom.2024.105458_bib25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41586-021-04177-9","article-title":"Combinatorial, additive and dose-dependent drug-microbiome associations","volume":"600","author":"Forslund","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2024.105458_bib26","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1210\/jc.2017-00138","article-title":"The FAT score, a fibrosis score of adipose tissue: predicting weight-loss outcome after gastric bypass","volume":"102","author":"Bel Lassen","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ebiom.2024.105458_bib27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ebiom.2024.105458_bib28","article-title":"Feature selection with theBorutaPackage","volume":"36","author":"Kursa","year":"2010","journal-title":"J\u00a0Stat Softw"},{"key":"10.1016\/j.ebiom.2024.105458_bib29","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.ebiom.2024.105458_bib30","article-title":"Mediation:Rpackage for causal mediation analysis","volume":"59","author":"Tingley","year":"2014","journal-title":"J\u00a0Stat Softw"},{"key":"10.1016\/j.ebiom.2024.105458_bib31","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1210\/endo.140.4.6617","article-title":"In\u00a0vivo and in\u00a0vitro ob gene expression and Leptin secretion in rat adipocytes: evidence for a regional specific regulation by sex steroid hormones","volume":"140","author":"Machinal","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.ebiom.2024.105458_bib32","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.2147\/JIR.S327858","article-title":"Transcription coactivator BCL3 acts as a potential regulator of lipid metabolism through the effects on inflammation","volume":"14","author":"Zhang","year":"2021","journal-title":"J\u00a0Inflamm Res"},{"key":"10.1016\/j.ebiom.2024.105458_bib33","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3390\/ijms22041639","article-title":"AP2M1 supports TGF-\u03b2 signals to promote collagen expression by inhibiting caveolin expression","volume":"22","author":"Lee","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ebiom.2024.105458_bib34","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.12417","article-title":"miR 221 regulates TGF-\u03b21-induced HSC activation through inhibiting autophagy by directly targeting LAMP2","volume":"24","author":"Cheng","year":"2021","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.ebiom.2024.105458_bib35","first-page":"5516","article-title":"Impact of bariatric surgery on adipose tissue biology","volume":"10","author":"Osorio-Conles","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.ebiom.2024.105458_bib36","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2337\/db07-1476","article-title":"Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans","volume":"57","author":"Zhang","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.ebiom.2024.105458_bib37","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1194\/jlr.M060574","article-title":"CDP-diacylglycerol synthases regulate the growth of lipid droplets and adipocyte development","volume":"57","author":"Qi","year":"2016","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.ebiom.2024.105458_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000776","article-title":"Plasma fibroblast growth factor 21 levels increase with ectopic fat accumulation and its receptor levels are decreased in the visceral fat of patients with type 2 diabetes","volume":"7","author":"Hong","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.ebiom.2024.105458_bib39","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.3390\/ijms21176030","article-title":"Adipose tissue fibrosis: mechanisms, models, and importance","volume":"21","author":"DeBari","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ebiom.2024.105458_bib40","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.3390\/nu13124340","article-title":"Fatty acid metabolism and derived-mediators distinctive of PPAR-\u03b1 activation in obese subjects Post bariatric surgery","volume":"13","author":"Manca","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.ebiom.2024.105458_bib41","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bbrc.2007.06.068","article-title":"PPARalpha is a key regulator of hepatic FGF21","volume":"360","author":"Lund\u00e5sen","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ebiom.2024.105458_bib42","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.2337\/db11-0672","article-title":"Fibroblast growth factor 21 (FGF21) in human cerebrospinal fluid: relationship with plasma FGF21 and body adiposity","volume":"60","author":"Tan","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.ebiom.2024.105458_bib43","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2337\/db18-0696","article-title":"FGF21 is a hormonal mediator of the human \u201cthrifty\u201d metabolic phenotype","volume":"68","author":"Vinales","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.ebiom.2024.105458_bib44","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cmet.2020.06.008","article-title":"FGF21 signals to glutamatergic neurons in the ventromedial hypothalamus to suppress carbohydrate intake","volume":"32","author":"Jensen-Cody","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.ebiom.2024.105458_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101564","article-title":"Pharmacological FGF21 signals to glutamatergic neurons to enhance leptin action and lower body weight during obesity","volume":"64","author":"Claflin","year":"2022","journal-title":"Mol Metab"},{"key":"10.1016\/j.ebiom.2024.105458_bib46","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000324128","article-title":"Alterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery","volume":"29","author":"Jansen","year":"2011","journal-title":"Dig Dis"},{"key":"10.1016\/j.ebiom.2024.105458_bib47","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ijo.2011.100","article-title":"Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity","volume":"36","author":"G\u00f3mez-Ambrosi","year":"2012","journal-title":"Int J Obes"},{"key":"10.1016\/j.ebiom.2024.105458_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201600725","article-title":"A\u00a0low-protein diet induces body weight loss and browning of subcutaneous white adipose tissue through enhanced expression of hepatic fibroblast growth factor 21 (FGF21)","volume":"61","author":"P\u00e9rez-Mart\u00ed","year":"2017","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.ebiom.2024.105458_bib49","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.celrep.2018.03.070","article-title":"A\u00a0common allele in FGF21 associated with sugar intake is associated with body shape, lower total body-fat percentage, and higher blood pressure","volume":"23","author":"Frayling","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2024.105458_bib50","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/j.gastro.2010.04.054","article-title":"Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease","volume":"139","author":"Dushay","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ebiom.2024.105458_bib51","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.molmet.2015.04.002","article-title":"Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes","volume":"4","author":"Berti","year":"2015","journal-title":"Mol Metab"},{"key":"10.1016\/j.ebiom.2024.105458_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1089214","article-title":"The potential function and clinical application of FGF21 in metabolic diseases","volume":"13","author":"Chen","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ebiom.2024.105458_bib53","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.2337\/dc18-0567","article-title":"Long-term relapse of type 2 diabetes after roux-en-Y gastric bypass: prediction and clinical relevance","volume":"41","author":"Deb\u00e9dat","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ebiom.2024.105458_bib54","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1007\/s11695-023-06702-3","article-title":"3-month post-operative increase in FGF21 is predictive of one-year weight loss after bariatric surgery","volume":"33","author":"De Luca","year":"2023","journal-title":"Obes Surg"},{"key":"10.1016\/j.ebiom.2024.105458_bib55","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molmet.2014.02.002","article-title":"Integrated physiology and systems biology of PPAR\u03b1","volume":"3","author":"Kersten","year":"2014","journal-title":"Mol Metab"},{"key":"10.1016\/j.ebiom.2024.105458_bib56","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.molmet.2016.08.005","article-title":"Roux-en-Y gastric bypass surgery is effective in fibroblast growth factor-21 deficient mice","volume":"5","author":"Morrison","year":"2016","journal-title":"Mol Metab"},{"key":"10.1016\/j.ebiom.2024.105458_bib57","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ijo.2013.152","article-title":"Gene expression profiling in subcutaneous, visceral and epigastric adipose tissues of patients with extreme obesity","volume":"38","author":"Gerhard","year":"2014","journal-title":"Int J Obes"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424004948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424004948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T16:58:50Z","timestamp":1733936330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424004948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":57,"alternative-id":["S2352396424004948"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105458","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FGF21 and its underlying adipose tissue-liver axis inform cardiometabolic burden and improvement in obesity after metabolic surgery","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105458","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105458"}}